IHH Healthcare Share Price

Equities

IHH

MYL5225OO007

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA 03:30:00 16/07/2024 am IST 5-day change 1st Jan Change
6.35 MYR +0.16% Intraday chart for IHH Healthcare +0.47% +5.31%

Financials

Sales 2024 * 22.46B 4.81B 401B Sales 2025 * 24.02B 5.14B 429B Capitalization 55.92B 11.97B 999B
Net income 2024 * 1.88B 403M 33.66B Net income 2025 * 2.03B 434M 36.25B EV / Sales 2024 * 2.83 x
Net Debt 2024 * 7.55B 1.61B 135B Net Debt 2025 * 6.41B 1.37B 114B EV / Sales 2025 * 2.6 x
P/E ratio 2024 *
30.4 x
P/E ratio 2025 *
28.2 x
Employees 70,000
Yield 2024 *
1.26%
Yield 2025 *
1.32%
Free-Float 24.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.16%
1 week+0.47%
Current month+0.79%
1 month+1.60%
3 months+5.31%
6 months+4.79%
Current year+5.31%
More quotes
1 week
6.29
Extreme 6.29
6.39
1 month
6.15
Extreme 6.15
6.39
Current year
5.93
Extreme 5.93
6.43
1 year
5.72
Extreme 5.72
6.43
3 years
5.44
Extreme 5.44
7.34
5 years
4.55
Extreme 4.55
7.34
10 years
4.54
Extreme 4.54
7.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 01/23/01
Investor Relations Contact - -
Corporate Officer/Principal 58 01/21/01
Members of the board TitleAgeSince
Director/Board Member 67 24/12/24
Director/Board Member 64 01/21/01
Director/Board Member 66 16/11/16
More insiders
Date Price Change Volume
16/24/16 6.35 +0.16% 3 649 100
15/24/15 6.34 +0.16% 7,070,400
12/24/12 6.33 -0.16% 5,375,000
11/24/11 6.34 +0.63% 10,619,200
10/24/10 6.3 0.00% 6,319,900

End-of-day quote BURSA MALAYSIA, July 16, 2024

More quotes
IHH Healthcare Berhad is a Malaysia-based integrated healthcare provider. The Company's segments include Hospital and Healthcare, IMU Health, Labs, PLife REIT and Others. It operates its Hospital and Healthcare segment in Singapore, Malaysia, India, Greater China, Turkey and Europe and Southeast Asia. The IMU Health segment is engaged in providing educational services. The Labs segment provides diagnostic laboratory services. The PLife REIT segment is a real estate investment trust. Through its portfolio of brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai and Parkway, the Company offers its patients comprehensive and personalized care ranging from primary to quaternary, and even ancillary services such as laboratory, diagnostics, imaging, and rehabilitation. It provides day-to-day healthcare services through outpatient treatment, routine check-ups, and vaccinations. Its secondary care comprises specialist consultation, local surgeries, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
6.35 MYR
Average target price
7.26 MYR
Spread / Average Target
+14.32%
Consensus